Competitive Strategy and Market Penetration of Indigenous Pharmaceutical Companies in Nigeria

This study examines the competitive strategies employed by indigenous pharmaceutical companies in Nigeria and their effect on domestic market penetration. Despite government policy preference for locally manufactured medicines, imported pharmaceutical products continue to command significant market share, challenging indigenous manufacturers to refine their competitive approaches. The research employs a survey design targeting production directors, marketing managers, and regulatory affairs officers of twelve indigenous pharmaceutical firms operating in Lagos, Ogun, and Anambra. A total of 90 respondents were selected through stratified sampling. Questionnaires and semi-structured interviews provided primary data. Analysis used descriptive statistics and regression analysis. Findings indicate that indigenous pharmaceutical companies competing on the basis of price leadership combined with local distribution network depth achieve the strongest domestic market penetration outcomes. Product quality certification through NAFDAC's approved manufacturing standards is identified as an essential competitive prerequisite rather than a differentiating strategy. The study also finds that strategic investment in packaging design and brand communication that emphasizes local manufacturing authenticity is increasingly effective in shifting consumer preference toward indigenous products. The research concludes that indigenous pharmaceutical companies must adopt integrated competitive strategies that combine quality assurance, price discipline, and brand investment to accelerate market penetration. Keywords: competitive strategy, market penetration, pharmaceutical companies, Nigeria, indigenous manufacturers.